Navigation Links
Quark Pharmaceuticals Reports Favorable Interim Results from Phase I Clinical Study of QPI-1007 in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Date:1/4/2012

iliary artery. Vision loss resulting from NAION is typically sudden and painless, and in most cases patients have permanent visual deficits. There are no approved therapies available for these patients.

About Quark Pharmaceuticals, Inc.

Quark Pharmaceuticals, Inc., is a clinical-stage pharmaceutical company engaged in discovering and developing novel RNAi-based therapeutics. The Company has a fully integrated drug development platform that spans therapeutic target identification based on its proprietary gene discovery technology, to clinical drug development. Quark has three product candidates in clinical development in five different disease indications of which four are in Phase 2. QPI-1007, a chemically modified synthetic siRNA, is Quark's first drug candidate based on novel siRNA structures developed though an internal program conducted by Quark in collaboration with BioSpring AG.

Quark is committed to leveraging a broad research pipeline of siRNA drug candidates and novel siRNA structures to develop additional RNAi drug candidates.

Quark is headquartered in Fremont, California and operates research and development facilities in Boulder, Colorado and Ness-Ziona, Israel. Additional information is available at www.quarkpharma.com.

(1) The Ischemic Optic Neuropathy Decompression Trial Research Group (1995). Optic Nerve Decompression Surgery for Nonarteritic Anteriror Ischemic Optic Neuropathy (NAION) is Not Effective and May Be Harmful. JAMA, Vol.273, pp.625 – 632; and (2) Hayreh S.S. & Zimmerman M.B. (2008). Non-arteritic Anterior Ischemic Optic Neuropathy. Natural History of Visual Outcome. J. Ophthalmology, pp.298-305.

 

'/>"/>

Quark Pharmaceuticals, Inc.

Juliana Friedman

+972 89 30 5111

jfriedman@quarkpharma.com

 

 


SOURCE Quark Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
10. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)...  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... non-statutory stock options to purchase an aggregate of 67,700 ... The awards were made pursuant to the NASDAQ inducement ... employment compensation. The inducement grants were approved ... are being made as an inducement material to each ...
(Date:8/1/2014)... 2014  With monumental health reform coming into effect, ... language. Clinical efficacy is no longer the sole driver ... like PCORI are directing roughly $1 billion a year ... and environments, the federal healthcare ecosystem is changing, and ... outcomes and managed markets to the right people in ...
(Date:8/1/2014)... LAVAL, Quebec and NEW YORK ... Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management, L.P. ... by Allergan, Inc. (NYSE: AGN ) in ... Pershing Square regarding the tender offer rules.  ... an attempt to interfere with shareholders, efforts to call ...
Breaking Medicine Technology:PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 2Pharmaceuticals Learning the Language of the New Healthcare Landscape 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 2Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 4Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 5Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 6
... 15 Dynatronics Corporation (Nasdaq: DYNT ) today announced ... from Nasdaq stating that the Company has not complied with ... , Nasdaq provides the Company an opportunity to appeal this ... authorized to grant up to 180 additional calendar days to ...
... Verathon Inc. is pleased to introduce the GlideScope(®) ... views in DVD clarity, enabling quick intubation. The ... and digital camera, offers integrated real-time recording as well ... This latest addition to the GlideScope(®) brand also provides ...
Cached Medicine Technology:Verathon Introduces the GlideScope(R) Cobalt Advanced Video Laryngoscope (AVL); New Digital Technology Facilitates Quick Intubations 2
(Date:8/1/2014)... August 02, 2014 The successful development ... stamping business of Guangdong FODAY Automobile Co.,LTD. As early ... company had already organized an excellent team to develop ... of detailed, in-depth technical plans. The company’s vice president ... in the direct involvement of the specific arrangement and ...
(Date:8/1/2014)... one of the most famous dress suppliers in the world, ... online. At the moment, all the brand new items ... to the company’s senior spokesman, the special offer will last ... is limited. Those who are thinking of buying cheap bridesmaid ... All its products are delicately made by top designers. ...
(Date:8/1/2014)... Cannabis use among young people has spiked, with ... used marijuana at least once and 17 percent admitting to ... Drugs, Say ‘Yes to Life,’ volunteers from the Church of ... with factual information about drugs, to help reverse this alarming ... to Drugs, Say ‘Yes’ to Life,” volunteers have distributed 40,000 ...
(Date:8/1/2014)... The Judicial Panel on Multidistrict Litigation ... therapy caused strokes, heart attacks, and other injuries in ... F. Kennelly as the transferee judge and ordered what ... federal court. , As one of his first organizing ... of attorneys who will move the litigation forward on ...
(Date:8/1/2014)... Diego School of Medicine report that dietary capsaicin ... activation of a receptor on cells lining the intestines ... risk of colorectal tumors. , The findings are published ... Journal of Clinical Investigation . , The receptor or ... neurons, where it acts as a sentinel for heat, ...
Breaking Medicine News(10 mins):Health News:FODAY Automobile Company Is Now Working On The C60F FODAY Project 2Health News:iFitDress.com: Top Bridesmaid Dresses For The Global Customers 2Health News:Addressing a Serious Issue Affecting German Teens 2Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Pepper and halt: Spicy chemical may inhibit gut tumors 2
... over 100 NFL Legends Announced, TAMPA, Fla., ... (GGAF) today announced an unprecedented humanitarian,initiative to assist ... U.S. Military Special Operations personnel and their families,through ... partnership today and unveiled a Gridiron Greats Super ...
... Mickey,s accidental death (October 18th) Hunter has been,changing ... Outreach,Foundation as National Spokesperson., CHICAGO, Nov. 12 ... Epilepsy Outreach Foundation (AEOF),joins with Hunter Tylo of ... nationwide,campaign to raise awareness of Epilepsy and educate ...
... accuracy of their annual formulations for human influenza vaccines ... the time, especially for seniors. Perhaps in part because ... upcoming influenza strains, approximately 36,000 people die each year ... the case of hurricanes, early warning of the location ...
... Nov. 12 As the exclusive official,breaking news service ... PR Newswire is featuring profiles of the exhibiting,organizations. The ... Company : Linemaster Switch ... Web URL : ...
... to ... reduces errors and hospital costs, DAYTONA BEACH, ... medication error reduction and hospital pharmacy I.V.,room automation, recently ... IntelliFill i.v.(TM), by the Alegent Health System. The,largest not-for-profit, ...
... Increased use of computers to create predictive models ... organised by the European Science Foundation (ESF), which ... the field. Human disease research produces an enormous ... animal models, high throughput genetic screening of human ...
Cached Medicine News:Health News:Warriors Unite: Mike Ditka & the Gridiron Greats Form Partnership to Assist Retired NFL Players & U.S. Military Special Operations Personnel 2Health News:Warriors Unite: Mike Ditka & the Gridiron Greats Form Partnership to Assist Retired NFL Players & U.S. Military Special Operations Personnel 3Health News:November: National Epilepsy Awareness Month Actress Hunter Tylo Turns Tragic Loss Into Hope 2Health News:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 2Health News:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 3Health News:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 4Health News:Linemaster Switch Corporation Exhibiting at MEDICA 2008 2Health News:Alegent Health System Automates I.V. Preparation to Enhance Patient Safety 2Health News:Computers make sense of experiments on human disease 2Health News:Computers make sense of experiments on human disease 3
... Proven tension-free sling technology ... porcine acellular collagen matrix sling, ... tissue-to-tissue contact between sling and ... urethral or vaginal abrasion or ...
... Delivers the advanced performance ... exceptional strength, versatility, and durability ... implant that augments the effectiveness ... pelvic floor reconstruction. Comprised of ...
... system is a state-of-the-art, comprehensive cardiac ... programs, modalities, and parameters are highly ... multiple applications including cardiac and pulmonary ... clinics. Its open architecture delivers flexibility ...
NephroMax High Pressure Nephrostomy Balloon Catheter allows one-step, atraumatic dilatation of the nephrostomy tract....
Medicine Products: